Padillo FJ - Search Results

1

Improving outcomes in pancreatic cancer: key points in perioperative management.

Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, Gómez MA, Muntané J, Padillo FJ. Alamo JM, et al. Among authors: padillo fj. World J Gastroenterol. 2014 Oct 21;20(39):14237-45. doi: 10.3748/wjg.v20.i39.14237. World J Gastroenterol. 2014. PMID: 25339810 Free PMC article. Review.

2

Factors predicting nutritional derangements in patients with obstructive jaundice: multivariate analysis.

Padillo FJ, Andicoberry B, Muntane J, Lozano JM, Miño G, Sitges-Serra A, Pera-Madrazo C. Padillo FJ, et al. World J Surg. 2001 Apr;25(4):413-8. doi: 10.1007/s002680020043. World J Surg. 2001. PMID: 11344390

3

Cytokines and acute-phase response markers derangements in patients with obstructive jaundice.

Padillo FJ, Andicoberry B, Muntane J, Lozano JM, Miño G, Sitges-Serra A, Solorzano G, Pera-Madrazo C. Padillo FJ, et al. Hepatogastroenterology. 2001 Mar-Apr;48(38):378-81. Hepatogastroenterology. 2001. PMID: 11379313

4

Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice.

Padillo FJ, Muntane J, Montero JL, Briceño J, Miño G, Solorzano G, Sitges-Serra A, Pera-Madrazo C. Padillo FJ, et al. World J Surg. 2002 Nov;26(11):1328-32. doi: 10.1007/s00268-002-6232-9. Epub 2002 Sep 26. World J Surg. 2002. PMID: 12297927 Clinical Trial.

5

Beneficial properties of melatonin in an experimental model of pancreatic cancer.

Ruiz-Rabelo JF, Vázquez R, Perea MD, Cruz A, González R, Romero A, Muñoz-Villanueva MC, Túnez I, Montilla P, Muntané J, Padillo FJ. Ruiz-Rabelo JF, et al. Among authors: padillo fj. J Pineal Res. 2007 Oct;43(3):270-5. doi: 10.1111/j.1600-079X.2007.00472.x. J Pineal Res. 2007. PMID: 17803524

6

Anti-TNF-alpha treatment and bile duct drainage restore cellular immunity and prevent tissue injury in experimental obstructive jaundice.

Padillo FJ, Cruz A, Segura-Jiménez I, Ruiz-Rabelo J, Vázquez-Ezquerra MR, Perea-Alvarez MD, Peña J, Briceño J, Muntané J. Padillo FJ, et al. Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):855-60. doi: 10.1177/039463200702000425. Int J Immunopathol Pharmacol. 2007. PMID: 18179761 Free article.

7

Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer.

Padillo FJ, Ruiz-Rabelo JF, Cruz A, Perea MD, Tasset I, Montilla P, Túnez I, Muntané J. Padillo FJ, et al. J Pineal Res. 2010 Oct;49(3):264-70. doi: 10.1111/j.1600-079X.2010.00791.x. Epub 2010 Jul 7. J Pineal Res. 2010. PMID: 20626589

8

Effects of capecitabine and celecoxib in experimental pancreatic cancer.

Arjona-Sánchez A, Ruiz-Rabelo J, Perea MD, Vázquez R, Cruz A, Muñoz Mdel C, Túnez I, Muntané J, Padillo FJ. Arjona-Sánchez A, et al. Among authors: padillo fj. Pancreatology. 2010;10(5):641-7. doi: 10.1159/000288708. Epub 2010 Nov 5. Pancreatology. 2010. PMID: 21051919

9

Results of liver transplantation with donors older than 70 years: a case-control study.

Álamo JM, Barrera L, Marín LM, Bernal C, Suárez G, Serrano J, Gómez MA, Padillo FJ. Álamo JM, et al. Among authors: padillo fj. Transplant Proc. 2011 Jul-Aug;43(6):2227-9. doi: 10.1016/j.transproceed.2011.05.016. Transplant Proc. 2011. PMID: 21839240

10

Liver transplantation in patients with cryptogenic cirrhosis: long-term follow-up.

Álamo JM, Bernal C, Barrera L, Marín LM, Suárez G, Serrano J, Gómez MA, Padillo FJ. Álamo JM, et al. Among authors: padillo fj. Transplant Proc. 2011 Jul-Aug;43(6):2230-2. doi: 10.1016/j.transproceed.2011.05.017. Transplant Proc. 2011. PMID: 21839241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page